Inflammation and Coagulation: Linked Processes Potentially Regulated Through a Common Pathway Mediated by Protein C

Unraveling the biochemical basis of the complex process of blood coagulation has been the focus of intense investigation for more than 30 years. During this period of time, considerable progress has been made in elucidating the structure and assembly of the coagulation complexes (for a review, see ref. 1). From our perspective, the framework of the biochemical basis of the assembly of the coagulation complexes provided the basis for examining the potential cross talk between inflammatory injury and coagulation. The importance of the linkage between inflammation and coagulation is manifest most dramatically in gram negative septic shock. During this process, leukocytes, platelets and monocytes are activated, cytokines are liberated, fibrinogen is consumed and massive vascular damage ensues. In this process, tissue factor is formed de novo and protein C is activated (for a review, see ref. 2). While each of these events definitely occur in the shock process, the influence of each event on other events and their relative contribution to the vascular damage and death are only beginning to emerge. The development of quantitative binding and kinetic assays has led to a second important advance — the appreciation of the roles of endothelial cells, neutrophils, monocyte/macrophage and platelets in these processes (1). In particular, cellular activation now appears to be central to the control of blood coagulation. It is cellular activation that probably constitutes a major link between inflammation, coagulation and vascular damage. This chapter will review our concepts of how these diverse processes may be linked. Our interests have focused on inflammation-coagulation interactions in three areas: 1) E. coli induced shock and disseminated intravascular coagulation (DIC); 2) venous thrombosis; and 3) reperfusion injury. The basic approach that has been taken is to combine basic information with clinical observations to design specific physiological experiments to test the relative importance of particular regulatory molecules on each of the above processes.

[1]  V. Gurewich,et al.  Isolation and characterization of an in vivo thrombin-induced anticoagulant activity. , 2009, Scandinavian journal of haematology.

[2]  C. Esmon,et al.  DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. , 1991, Blood.

[3]  C. Esmon,et al.  Protein C Activation Following Coronary Artery Occlusion in the In Situ Porcine Heart , 1991, Circulation.

[4]  D. Isenberg,et al.  Total and free protein S in systemic lupus erythematosus. , 1990, Thrombosis research.

[5]  S. Rapaport,et al.  Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. , 1990, Blood.

[6]  C. Maury,et al.  Circulating tumour necrosis factor‐α (cachectin) in myocardial infarction , 1989 .

[7]  R. Rosenberg,et al.  Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells , 1988, Molecular and cellular biology.

[8]  L. McManus,et al.  Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. , 1988, Circulation.

[9]  C. Esmon,et al.  Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. , 1988, The Journal of clinical investigation.

[10]  K. Mann,et al.  Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles. , 1988, The Journal of biological chemistry.

[11]  R. Rosenberg,et al.  Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor , 1987, Journal of cellular physiology.

[12]  A. Chang,et al.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. , 1987, The Journal of clinical investigation.

[13]  B. Dahlbäck Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. , 1986, The Journal of biological chemistry.

[14]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[15]  C. Esmon,et al.  The roles of protein C and thrombomodulin in the regulation of blood coagulation. , 1984, The Journal of biological chemistry.

[16]  C. Esmon,et al.  Familial protein S deficiency is associated with recurrent thrombosis. , 1984, The Journal of clinical investigation.

[17]  F. Taylor,et al.  A model for thrombin protection against endotoxin. , 1984, Thrombosis research.

[18]  C. Esmon,et al.  Activation of protein C in vivo. , 1982, The Journal of clinical investigation.

[19]  A. Chang,et al.  Extracorporeal perfusion without exogenous anticoagulation: its protective role in endotoxin shock. , 1982, Circulatory shock.

[20]  C. Esmon,et al.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[21]  F. Walker Regulation of activated protein C by a new protein. A possible function for bovine protein S. , 1980, The Journal of biological chemistry.

[22]  A. McKee,et al.  Membrane oxygenation in baboons without anticoagulants. , 1977, The Journal of surgical research.

[23]  K. Mann,et al.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes. , 1990, Blood.

[24]  C. Esmon,et al.  Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. , 1989, Blood.

[25]  P. Craddock Complement - Mediated Intravascular Leukostasis and Endothelial Cell Injury , 1982 .

[26]  F. Taylor,et al.  Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. , 1978, Circulatory shock.

[27]  J. Haerem Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. , 1972, Atherosclerosis.